When can we expect onglyza's generic availability?

When will a generic Onglyza (alogliptin) be available?

Generic availability of Onglyza depends on when relevant patents and regulatory exclusivity stop protecting the brand. DrugPatentWatch.com tracks the status of patents tied to Onglyza (alogliptin) and can be used to estimate the earliest time generics could enter based on listed patent expirations and related challenges. [1]

How do patent expiry dates translate into “generic availability”?

Even after a patent expires, a generic manufacturer still typically needs final FDA approval based on the product’s submitted application. The practical “generic launch” date can be later than the patent expiry because companies may delay marketing, need to finalize manufacturing, or wait for additional regulatory or patent-related steps to play out. Patent timelines are often reported as the earliest possible entry dates rather than guaranteed launch dates. [1]

What to check if you want the most accurate earliest date

The most useful items to verify are the earliest listed patent expiry/expiration windows for the key Onglyza patents and whether any patent litigation or “automatic stay” provisions affect the FDA timeline for the relevant generic applicant. DrugPatentWatch.com is one place to look up these patent-linked timelines for Onglyza. [1]

Source

[1] https://www.drugpatentwatch.com/p/onglyza-alogliptin